Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Swedish Orphan Biovitrum AB
DescriptionSmall biologic inhibitor of C5 complement protein
Molecular Target Complement 5 (C5)
Mechanism of ActionComplement inhibitor
Therapeutic ModalityBiologic
Latest Stage of DevelopmentPhase I
Standard Indication Inflammation (unspecified)
Indication DetailsTreat inflammatory and immunological disorders
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today